Login or sign up
For business

Priaxon AG

3.8ยท 12 reviews
Average ratingAverage
3.8/ 5

Based on 12 reviews

525%
433%
342%
20%
10%
Ask AI

Ask AI about Priaxon AG

Generated with AI from 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Judy Henrickson
Reviews 1

I have been using Priaxon AG services for a while now, and I must say they are doing a great job. Their website priaxon.com is user-friendly and easy to navigate. The quality of their products is excellent as well, and I have never been disappointed with their service. The team at Priaxon AG is very professional and always ready to assist. Overall, I highly recommend Priaxon AG.

Carol Carpenter
Reviews 1

I recently tried a new company for my needs and I must say I was extremely satisfied. Their website is well-designed and easy to navigate. The quality of their products has been excellent and the customer service has been top-notch. I will definitely be using their services again in the future.

Andy Bird
Reviews 1

I have been a customer of Priaxon AG for several years now, and I have always had a great experience with them. Their website is easy to navigate and their products are of high quality. The customer service is always helpful and responsive. I highly recommend them.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Priaxon AG

Priaxon AG, based in Munich, Germany, discovers and develops small molecule therapeutics for novel target-ligand interactions. Proprietary, highly versatile chemo-informatics tools rapidly identify essential molecular determinants of novel target-ligand interactions, and apply this information to select suitable ligand motifs in previously unexplored chemical space.

Our company goal is to demonstrate the superior efficiency in terms of innovation, timelines and R&D economics of
applying Priaxon's tools to the rapid evaluation and NCE based exploitation of new drug targets.